Since direct measurement of cytokine levels including IL-6 is technically challenging and time-consuming, the CRP level can serve as an indirect marker of CRS related cytokine elevation and can be used as a predictive marker of the risk for the development of severe CRS and for monitoring patient response to treatment [105]. The gene discussed is CRP; the disease is congenital rubella syndrome.